{"title":"Drug watch. Pipeline progress: then and now.","authors":"John Hawes","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The antiretroviral drug pipeline was last reviewed in BETA three years ago (see \"The HIV/AIDS drug pipeline: a status report\" in the Summer/Autumn 2002 issue). That report called on pharmaceutical companies to \"ensure a steadier stream of innovative and affordable approaches to managing HIV infection.\" Is this goal being achieved?</p>","PeriodicalId":80644,"journal":{"name":"BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation","volume":"17 4","pages":"15-7"},"PeriodicalIF":0.0000,"publicationDate":"2005-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The antiretroviral drug pipeline was last reviewed in BETA three years ago (see "The HIV/AIDS drug pipeline: a status report" in the Summer/Autumn 2002 issue). That report called on pharmaceutical companies to "ensure a steadier stream of innovative and affordable approaches to managing HIV infection." Is this goal being achieved?